CN116445306B - Schizosaccharomyces pombe and its application in improving skin condition - Google Patents
Schizosaccharomyces pombe and its application in improving skin condition Download PDFInfo
- Publication number
- CN116445306B CN116445306B CN202310706432.3A CN202310706432A CN116445306B CN 116445306 B CN116445306 B CN 116445306B CN 202310706432 A CN202310706432 A CN 202310706432A CN 116445306 B CN116445306 B CN 116445306B
- Authority
- CN
- China
- Prior art keywords
- schizosaccharomyces pombe
- genes
- cell
- extracellular matrix
- regulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000235347 Schizosaccharomyces pombe Species 0.000 title claims abstract description 52
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 12
- 230000001737 promoting effect Effects 0.000 claims abstract description 12
- 230000004663 cell proliferation Effects 0.000 claims abstract description 11
- 230000008591 skin barrier function Effects 0.000 claims abstract description 10
- 239000002537 cosmetic Substances 0.000 claims abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 61
- 210000004027 cell Anatomy 0.000 claims description 51
- 230000014509 gene expression Effects 0.000 claims description 49
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 41
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 41
- 210000002744 extracellular matrix Anatomy 0.000 claims description 41
- 239000006228 supernatant Substances 0.000 claims description 32
- 239000003963 antioxidant agent Substances 0.000 claims description 30
- 238000006731 degradation reaction Methods 0.000 claims description 25
- 230000003078 antioxidant effect Effects 0.000 claims description 24
- 230000006907 apoptotic process Effects 0.000 claims description 24
- 230000015556 catabolic process Effects 0.000 claims description 24
- 210000003491 skin Anatomy 0.000 claims description 22
- 238000002360 preparation method Methods 0.000 claims description 18
- 230000008439 repair process Effects 0.000 claims description 18
- 210000002510 keratinocyte Anatomy 0.000 claims description 17
- 239000000047 product Substances 0.000 claims description 15
- 230000015572 biosynthetic process Effects 0.000 claims description 10
- 239000003102 growth factor Substances 0.000 claims description 10
- 238000003786 synthesis reaction Methods 0.000 claims description 10
- 241000235346 Schizosaccharomyces Species 0.000 claims description 8
- 230000010261 cell growth Effects 0.000 claims description 8
- 239000013592 cell lysate Substances 0.000 claims description 8
- 230000003827 upregulation Effects 0.000 claims description 8
- 230000002222 downregulating effect Effects 0.000 claims description 7
- 102000003954 Autophagy-Related Proteins Human genes 0.000 claims description 6
- 108010082399 Autophagy-Related Proteins Proteins 0.000 claims description 6
- 102100035290 Fibroblast growth factor 13 Human genes 0.000 claims description 6
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 6
- 230000004888 barrier function Effects 0.000 claims description 6
- -1 DPPH free radical Chemical class 0.000 claims description 5
- 102100028071 Fibroblast growth factor 7 Human genes 0.000 claims description 5
- 101001060261 Homo sapiens Fibroblast growth factor 7 Proteins 0.000 claims description 5
- 230000003712 anti-aging effect Effects 0.000 claims description 5
- 230000002401 inhibitory effect Effects 0.000 claims description 5
- 230000003647 oxidation Effects 0.000 claims description 5
- 238000007254 oxidation reaction Methods 0.000 claims description 5
- 101000704221 Homo sapiens Serine palmitoyltransferase small subunit A Proteins 0.000 claims description 4
- 102100031872 Serine palmitoyltransferase small subunit A Human genes 0.000 claims description 4
- 230000035755 proliferation Effects 0.000 claims description 4
- 102100040993 Collagen alpha-1(XIII) chain Human genes 0.000 claims description 2
- 101000749004 Homo sapiens Collagen alpha-1(XIII) chain Proteins 0.000 claims description 2
- 230000001413 cellular effect Effects 0.000 claims description 2
- 229940124644 immune regulator Drugs 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 230000002000 scavenging effect Effects 0.000 claims description 2
- 230000003833 cell viability Effects 0.000 claims 1
- 230000032683 aging Effects 0.000 abstract description 9
- 230000006870 function Effects 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000006166 lysate Substances 0.000 description 24
- 238000000034 method Methods 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 14
- 238000011160 research Methods 0.000 description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- 230000004900 autophagic degradation Effects 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 238000011529 RT qPCR Methods 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- 210000002950 fibroblast Anatomy 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 230000007760 free radical scavenging Effects 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000002247 constant time method Methods 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004792 oxidative damage Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 230000004957 immunoregulator effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000203069 Archaea Species 0.000 description 1
- 102000002029 Claudin Human genes 0.000 description 1
- 108050009302 Claudin Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 1
- 108010020382 Hepatocyte Nuclear Factor 1-alpha Proteins 0.000 description 1
- 102100021866 Hepatocyte growth factor Human genes 0.000 description 1
- 102100022057 Hepatocyte nuclear factor 1-alpha Human genes 0.000 description 1
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 102100024177 Microtubule-associated proteins 1A/1B light chain 3B Human genes 0.000 description 1
- 101710171597 Microtubule-associated proteins 1A/1B light chain 3B Proteins 0.000 description 1
- 102000007561 NF-E2-Related Factor 2 Human genes 0.000 description 1
- 108010071382 NF-E2-Related Factor 2 Proteins 0.000 description 1
- 102000003840 Opioid Receptors Human genes 0.000 description 1
- 108090000137 Opioid Receptors Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102100032543 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Human genes 0.000 description 1
- 101710132081 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Proteins 0.000 description 1
- 108010044625 Proto-Oncogene Proteins c-mos Proteins 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 102000011990 Sirtuin Human genes 0.000 description 1
- 108050002485 Sirtuin Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 102000055102 bcl-2-Associated X Human genes 0.000 description 1
- 108700000707 bcl-2-Associated X Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000036566 epidermal hyperplasia Effects 0.000 description 1
- 210000001808 exosome Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003936 merozoite Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 230000037204 skin physiology Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/165—Yeast isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a schizosaccharomyces pombe and application thereof in improving skin conditions, wherein the strain is schizosaccharomyces pombe @ the whole yeastSchizosaccharomyces pombe) SEUNEU-120 has been deposited in China center for type culture Collection with a deposit number of CCTCC NO: M20221432. The schizosaccharomyces pombe provided by the invention has the functions of promoting cell proliferation, repairing skin barrier, moisturizing and resisting aging, and can be used for preparing foods, medicines, cosmetics and the like.
Description
Technical Field
The invention relates to the technical field of microorganisms, in particular to schizosaccharomyces pombe and application thereof in improving skin conditions.
Background
The stratum corneum formed by the basal layer keratinocytes of the skin after undergoing directional differentiation can prevent various physical and chemical damages. The skin barrier function maintains normal operation of the skin physiological function by preventing loss of moisture, nutrients and the like, and simultaneously ensures that the organ tissues in the body are prevented from being affected by external harmful substances, thereby playing an important role in maintaining the homeostasis of the internal environment of the body.
Skin aging is a part of the aging process of the body and is the most intuitive organ for the aging process. The current research on skin aging is mainly on the aging of skin fibroblasts and keratinocytes. The histological changes of the aged dermis of the skin are mainly changes in the matrix composition of the skin, i.e. reduced collagen composition and abnormal elastic fiber deposition. The molecular change is mainly the abnormal expression of the epidermal hyperplasia and differentiation markers, and the expression of Matrix Metalloproteinase (MMP) is increased, for example, MMP1 is collagen degrading enzyme, is also a main factor for decomposing skin collagen fibers, can cause the aging of skin dermis, and is one of the indexes of skin aging. In the research of aging mechanism, it has been found that reducing apoptosis, reducing cell inflammation, increasing synthesis of extracellular matrix, reducing degradation thereof, improving antioxidant capacity of cells, etc. have all been demonstrated to slow aging of skin cells.
Skin is a complex and dynamic ecological system populated with bacteria, archaea, fungi and viruses. These microorganisms are collectively referred to as the skin microbiota and are the basis for skin physiology and immunity. Most microorganisms living on the skin appear to be symbiotic or reciprocal symbiotic under steady state conditions. Bacteria inhabit all layers of the skin, from the outer stratum corneum to the inner dermis. Microorganisms maintain skin barrier integrity critical to homeostasis and disease prevention. Therefore, the skin microecological related product developed by utilizing the microbial technology has wide application value in improving the skin state.
Disclosure of Invention
In view of this, the present invention provides a merozoite strain of Schizosaccharomyces pombe and its use for improving skin conditions.
The invention discloses schizosaccharomyces pombeSchizosaccharomyces pombe) In particular to schizosaccharomyces pombeSchizosaccharomyces pombe) SEUNEU-120 has been deposited in China center for type culture Collection with a deposit number of CCTCC NO: M20221432.
The invention also discloses application of the schizosaccharomyces pombe in preparing products for improving skin conditions.
Further, the above application, wherein the improving the skin condition comprises at least one of promoting cell proliferation, repairing skin barrier, moisturizing, and anti-aging.
In the present invention, repairing the skin barrier includes repairing SDS-induced cell damage and/or up-regulating expression of a barrier repair-related gene; the barrier repair related gene comprisesFLG、IVL、OVOL1AndOCLNat least one of them.
Furthermore, the invention takes HaCaT keratinocytes as a test object, and researches on the SDS damage repair capability of the schizosaccharomyces pombe prove that the schizosaccharomyces pombe can repair cell damage caused by SDS, improve the cell proliferation rate and up-regulate the expression of barrier repair related genes of non-damaged cells.
In the present invention, the moisturizing includes, but is not limited to, up-regulating expression of a moisturizing-related gene, which isGBA. The invention takes HaCaT keratinocyte as a test object, researches the moisturizing effect of the schizosaccharomyces pombe on the skin, and results show that the schizosaccharomyces pombe can up regulate the moisturizing related genesGBAIs effective in promoting skin cell moisture retention.
Further, the above application, wherein the anti-aging comprises at least one of the following:
up-regulating expression of genes involved in extracellular matrix synthesis, includingCOL1A1、COL13A1、SPTSSA、SMAD3AndMKXat least one of (a) and (b);
down-regulating expression of genes associated with degradation of extracellular matrix; the genes related to the degradation of the extracellular matrix compriseMMPAt least one of the family genes;
upregulating expression of a cellular antioxidant-associated gene comprisingNRF2、PTENAndSIRT-1at least one of (a) and (b);
up-regulating cell immune regulator related geneMORIs expressed by (a);
down-regulating apoptosis-related genesBAXAnd/orCaspase-9Is expressed by (a);
upregulation of cell autophagy-related genesLC3BIs expressed by (a);
upregulation inhibits apoptosisGenes related to apoptosisBCL-2Is expressed by (a);
up-regulating expression of a cell growth factor related gene comprisingFGF1、FGF2、FGF7、FGF21AndHGFat least one of (a) and (b);
scavenging DPPH free radical;
oxidation resistance.
In order to explore the anti-aging effect of schizosaccharomyces pombe, the invention detects the indexes related to cell aging, wherein the indexes comprise at least one of extracellular matrix synthesis, extracellular matrix degradation, cell oxidation resistance, cell immunity regulating factors, apoptosis, autophagy, apoptosis inhibition, cell growth factors, DPPH free radical removal and oxidation resistance.
In the present invention, the cell proliferation promoting means promotes proliferation of skin keratinocytes. The invention takes HaCaT keratinocytes as a test object to study the effect of promoting cell proliferation of the schizosaccharomyces pombe. The result shows that the schizosaccharomyces pombe can promote repair of HaCaT keratinocyte injury caused by SDS, improve the cell proliferation rate, and promote the proliferation rate to be 10.16-13.45%.
The invention takes HaCaT keratinocytes as a test object, and researches the influence of the schizosaccharomyces pombe on genes related to the synthesis of HaCaT extracellular matrix and genes related to degradation. The results show that the schizosaccharomyces pombe can up-regulate the genes related to the synthesis of extracellular matrixCOL1A1Promote synthesis of extracellular matrix, down-regulate degradation of extracellular matrix-related genesMMP1Inhibit degradation of extracellular matrix.
The invention takes HaCaT keratinocytes as a test object, and researches the influence of the schizosaccharomyces pombe on the autophagy of the HaCaT keratinocytes. The results show that the schizosaccharomyces pombe can up-regulate the cell autophagy related genesLC3BPromotes autophagy to clear aged cells.
The invention takes HaCaT keratinocytes as a test object, and researches the influence of the schizosaccharomyces pombe on the expression of the gene related to the oxidation resistance of the HaCaT keratinocytes. The results show that theGene related to up-regulating antioxidation of schizosaccharomyces pombeNRF2Enhancing the antioxidant capacity of the cells.
The invention takes HFF fibroblasts as a test object to study the influence of the schizosaccharomyces pombe on genes related to HFF extracellular matrix synthesis and genes related to degradation. The results show that the schizosaccharomyces pombe can up-regulate the genes related to the synthesis of extracellular matrixCOL13A1、SPTSSA、SMAD3AndMKXpromote synthesis of extracellular matrix, down-regulate degradation of extracellular matrix-related genesMMP3Inhibit degradation of extracellular matrix.
The invention takes HFF fibroblasts as a test object to study the influence of the schizosaccharomyces pombe on HFF apoptosis. The results show that the schizosaccharomyces pombe can down regulate the apoptosis related genesBAXAndCaspase-9is effective in inhibiting apoptosis.
The invention takes HFF fibroblasts as a test object, and researches the influence of the schizosaccharomyces pombe on the HFF cells to inhibit apoptosis. The results show that the schizosaccharomyces pombe can up-regulate and inhibit the apoptosis related genesBCL-2Is effective in inhibiting apoptosis.
The invention takes HFF fibroblasts as a test object to study the influence of the schizosaccharomyces pombe on the expression of the gene related to the HFF cell antioxidation. The results show that the schizosaccharomyces pombe can up-regulate the antioxidant related genesPTENAndSIRT-1enhancing the antioxidant capacity of the cells.
The invention takes HFF fibroblast as a test object, and researches the influence of the schizosaccharomyces pombe on the expression of HFF cell immunoregulatory factor related genes. The results show that the schizosaccharomyces pombe can up-regulate the genes related to the immune regulatorMOREnhancing the immunomodulatory ability of the cell.
The invention takes HFF fibroblast as a test object, and researches the influence of the schizosaccharomyces pombe on the expression of HFF cell growth factor related genes. The results show that the schizosaccharomyces pombe can up-regulate the cell growth factor related genesFGF1、FGF2、FGF7、FGF21AndHGFenhancing the growth capacity of the cells.
The invention takes schizosaccharomyces pombe as a test object, and researches the detection of the schizosaccharomyces pombe on DPPH free radical removal and total antioxidant capacity. The results show that the schizosaccharomyces pombe can remove DPPH free radicals and has antioxidant capacity, so that oxidative damage of cells is reduced.
Further, the above application, wherein the product is a food, a pharmaceutical or a cosmetic.
The invention also discloses a product for improving skin condition, which is prepared from the raw materials including the schizosaccharomyces pombe.
Further, the above products include supernatant of schizosaccharomyces pombe and thallus lysate.
Further, the dosage forms of the product of the present invention include, but are not limited to, at least one of creams, emulsions, oils, aqueous solutions, gels, powders, and freeze-drying.
The invention also provides a method of improving skin condition comprising using the slave product of the invention. The application method comprises smearing, external application, fumigation or injection, and the invention is not limited to the method.
The invention provides schizosaccharomyces pombeSchizosaccharomyces pombe) The culture medium is preserved in China Center for Type Culture Collection (CCTCC) with the preservation number of M20221432. Experiments show that the schizosaccharomyces pombe provided by the invention has the functions of promoting cell proliferation, repairing skin barrier, moisturizing and resisting aging, and can be used for preparing foods, medicines, cosmetics and the like.
Description of biological preservation
Schizosaccharomyces pombeSchizosaccharomyces pombe) SEUNEU-120 was deposited at China center for type culture Collection (China, university of Wuhan, wuhan) with a deposit number of CCTCC NO: M20221432 at 9 and 14 of 2022.
Detailed Description
The invention provides schizosaccharomyces pombe and application thereof. Those skilled in the art can, with the benefit of this disclosure, suitably modify the process parameters to achieve this. It is expressly noted that all such similar substitutions and modifications will be apparent to those skilled in the art, and are deemed to be included in the present invention. While the methods and applications of this invention have been described in terms of preferred embodiments, it will be apparent to those skilled in the relevant art that the invention can be practiced and practiced with modification and alteration and combination of the methods and applications herein without departing from the spirit and scope of the invention.
The schizosaccharomyces pombe strain SEUNEU-120 of the invention is derived from sugar cane molasses of guests of Guangxi Zhuang nationality, and is identified as schizosaccharomyces pombe through 26S rDNA identificationSchizosaccharomyces pombe). The strain SEUNEU-120 is round or oval under a microscope; growing on a wort solid flat plate to form milky white, matt colonies and tidy edges; the strain grows in a malt juice liquid culture medium in a uniform turbidity mode, the strain is white in precipitation after long-term placement, and the optimal growth temperature is 28 ℃.
Schizosaccharomyces pombeSchizosaccharomyces pombe) SEUNEU-120, accession number: china center for type culture Collection, address: in the Jiuqiu No. 299 university of Wuhan, hubei province, the date of preservation: and 2022, 9 and 14 days, wherein the preservation number is CCTCC NO: M20221432.
Furthermore, the present invention provides the use or product of the schizosaccharomyces pombe SEUNEU-120 in the form of a live or dead or sterilized intermittently, or in the form of a lysate and/or extract, or in the form of a yeast product, or in the form of a supernatant or derivative. Preferably, schizosaccharomyces pombe SEUNEU-120 is present in a form selected from the group consisting of supernatant or bacterial lysate. The derivative form is preferably selected from: metabolites, metabolic biological products, exosomes, probiotics, cell walls and components thereof, extracellular polysaccharides, and compounds containing immunogenic components.
The test materials used in the present invention are all commercially available products, and the present invention is further described below with reference to examples.
EXAMPLE 1 SEUNEU-120 isolation
Sampling in cane molasses. After the sample is properly treated, shaking and uniformly mixing the sample in normal saline, streaking the supernatant on a wort solid plate, culturing the wort solid plate at the constant temperature of 28 ℃ for 48 hours, and then picking white colonies, repeatedly inoculating and screening until uniform single colonies are obtained, and the colony is named as SEUNEU-120.
And (5) microscopic examination: the strain SEUNEU-120 is round or oval under a microscope; growing on a wort solid flat plate to form milky white, matt colonies and tidy edges; the strain grows in a malt juice liquid culture medium in a uniform turbidity manner, and the strain is white in precipitation after long-term placement.
EXAMPLE 2 nucleic acid identification of SEUNEU-120
1. 26S rDNA gene sequence analysis:
single colony is selected and placed in malt juice culture medium, after the culture is carried out at 28 ℃ overnight, the culture medium is centrifuged for 2min at 12000 revolutions to collect thalli, and the operation is carried out according to the step of extracting the yeast genome DNA kit. The primers adopt yeast universal primers NL1 and NL4, the PCR amplification system is a 50 mu L system, and the primers are pre-denatured for 5min at 95 ℃;94℃1min,52℃1min,72℃90s,36 cycles; extending at 72℃for 10min.
2. Results
The PCR product sequencing result is compared with the published standard sequence in GenBank (BLASTN) to obtain the SEUNEU-120 strain which is schizosaccharomyces pombeSchizosaccharomyces pombe）。
Example 3 SEUNEU-120 promoting SDS-induced repair of HaCaT injury in human immortalized keratinocytes
1. Preparation of SEUNEU-120 supernatant and thallus lysate:
selecting single colony of schizosaccharomyces pombe SEUNEU-120 in malt wort liquid medium, shake culturing at 28 ℃ for 16-18 h, detecting by using a microplate reader, and diluting with PBS to adjust OD 600 The cells were separated and precipitated by centrifugation at 12000 rpm for 2min, the supernatant was removed, inactivated at 121 ℃ for 30min under high pressure, and filtered through a 0.22 μm filter membrane to obtain an inactivated supernatant. The centrifugal precipitation thalli is washed twice by PBS, added with liquid nitrogen for grinding and crushing, the crushed bacterial mud is collected and resuspended to the volume when in centrifugation by PBS, then is crushed by ultrasonic for 20 minutes, and is inactivated at 121 ℃ for 30 minutes under high pressureObtaining the bacterial lysate.
2. Promoting HaCaT cell repair experiments
Inoculation of HaCaT cells (5×10) 4 cells/well) to 96-well plates, cultured overnight to cell attachment. 50. Mu.g/ml SDS was prepared, 100. Mu.l of each well was added thereto, and the mixture was incubated in a 5% carbon dioxide incubator at 37℃for 8 hours. 5% (V/V) supernatant and 10% (V/V) cell lysate (control group replaced supernatant or cell lysate with equal volume of PBS) were added to each well, respectively, and cultured for 24h. Mu.l of CCK-8 solution was added to each well, and incubated for 4 hours, and the absorbance at 450nm was measured for brightness A.
The cell proliferation rate was calculated as: cell proliferation rate= (experimental group a-control group a)/control group a x 100%, and the calculation results are shown in table 1.
TABLE 1 SEUNEU-120 promoting HaCaT cell repair
As shown in Table 1, both the SEUNEU-120 supernatant and the cell lysate promote repair of SDS-induced HaCaT keratinocyte injury, increase cell proliferation rate, and promote proliferation rate by 10.16-13.45%.
Example 4 SEUNEU-120 promotion of HaCaT Barrier maintenance-related Gene expression experiments
1. Preparation of SEUNEU-120 supernatant and thallus lysate:
the preparation is described in example 3.
2. Promote HaCaT barrier repair related gene expression experiment
Inoculated human immortalized keratinocyte HaCaT (2 ml/well, 5X 10 contained therein) 5 Cells) to 6-well plates, 5% carbon dioxide incubator at 37 ℃ overnight until cells adhere. Respectively adding 5% (V/V) supernatant and 10% (V/V) thallus lysate (the control group respectively replaces supernatant or thallus lysate with equal volume PBS), culturing for 24 hr, adding lysate, extracting total RNA of cells, detecting RNA concentration and purity, and reverse transcribing into cDNA to obtain final productGAPDHAs reference gene, real-time qPCR detection was usedFLG、IVL、OVOL1AndOCLNexpression of the genes. Respectively byThe control (relative gene expression fold f=1) was supplemented with an equal volume of PBS treatment group, using 2 -ΔΔCT The F value of each sample was calculated by the method. The results of the expression calculation of the SEUNEU-120 supernatant and the thallus lysate up-regulation repair gene are shown in Table 2 and Table 3 respectively.
The formula: f=2 -ΔΔCT Wherein:
△CT experiment =CT Experiment -CT Internal reference (experiment);
△CT control =CT Control -CT Internal control (control);
△△CT=△CT experiment -△CT And (3) controlling.
TABLE 2 expression of SEUNEU-120 supernatant up-regulating repair genes
TABLE 3 SEUNEU-120 bacterial lysate up-regulates the expression of repair genes
In vitro cell experiments show that the supernatant and the thallus lysate of the schizosaccharomyces pombe SEUNEU-120 have the up-regulated skin barrier repair related factor silk polymerized protein genesFLGEndothelial protein geneIVLOVO-like transcription factor 1 geneOVOL1And a claudin geneOCLNThe expression effect is that the gene expression quantity is up-regulated by 1.11-2.81 times. SEUNEU-120 has been shown to have an effect of promoting skin barrier repair.
Example 5 SEUNEU-120 up-regulation of HaCaT moisture-retention-related Gene expression experiments
1. Preparation of SEUNEU-120 thallus lysate:
the preparation is described in example 3.
2. Up-regulating HaCaT moisture-preserving related gene expression experiment
Inoculated human immortalized keratinocyte HaCaT (2 ml/well, 5X 10 contained therein) 5 Cells) to 6-well plate, 5% carbon dioxide incubator at 37 deg.cThe cells were cultured overnight until they adhered to the wall. Adding 10% (V/V) thallus lysate (the control group is replaced by equal volume PBS), culturing for 24 hr, adding lysate, extracting total RNA of cells, detecting RNA concentration and purity, and reverse transcribing into cDNAGAPDHAs reference gene, real-time qPCR detection was usedGBAExpression of the genes. The control (relative gene expression fold f=1) was equal volume PBS treated group, using 2 -ΔΔCT The F value of each sample was calculated by the method. The test results are shown in Table 4.
TABLE 4 SEUNEU-120 bacterial lysate up-regulates expression of moisturizing genes
In vitro cell experiments show that the schizosaccharomyces pombe SEUNEU-120 has glucose cerebrosidase gene related to up-regulation and moisture preservationGBAThe expression effect is that the gene expression quantity is up-regulated by 1.15-1.30 times. SEUNEU-120 has been shown to have skin moisturizing effects.
Example 6 SEUNEU-120 Regulation of light aging HaCaT extracellular matrix/antioxidant/autophagy/degradation of extracellular matrix-related Gene expression experiments
1. Preparation of SEUNEU-120 supernatant and thallus lysate:
the preparation is described in example 3.
2. HaCaT cell preparation and ultraviolet injury
HaCaT cells were digested and then subjected to a reaction at 0.5 ml/well (containing 2X 10 cells) 5 Cells) were inoculated into 24-well plates and incubated overnight at 37℃in a 5% carbon dioxide incubator. The total dose of cells in the well was 2J/cm 2 Is damaged by ultraviolet UVB irradiation.
3. SEUNEU-120 addition
5% (V/V) supernatant and 10% (V/V) cell lysate were added to each stimulated HaCaT cell (control group replaced supernatant/cell lysate with equal volume of PBS, respectively). Each group was incubated overnight at 37℃in parallel with 3.
4. qPCR method for detecting relative expression fold of extracellular matrix/antioxidant/autophagy/degradation extracellular matrix related genes
Removing culture medium from above cells, adding lysate, extracting total RNA of cells, detecting RNA concentration and purity, and reverse transcribing into cDNAGAPDHAs reference genes, real-time qPCR was used to detect extracellular matrix-related genesCOL1A1Antioxidant related genesNRF2Cell autophagy-related genesLC3BAnd degradation of extracellular matrix-related genesMMP1Is expressed by (a). Relative expression fold f=1, using 2 for control group genes -ΔΔCT The F value of each sample was calculated by the method.
Supernatant up-regulating cell autophagy related genesLC3BThe method comprises the steps of carrying out a first treatment on the surface of the Down-regulating degradation of extracellular matrix related genesMMP1. The results are shown in Table 5.
TABLE 5 SEUNEU-120 supernatant regulates the expression of genes involved in autophagy/degradation of extracellular matrix
Up-regulating extracellular matrix related genes by thallus lysateCOL1A1Antioxidant related genesNRF2Autophagy geneLC3BThe method comprises the steps of carrying out a first treatment on the surface of the Down-regulating degradation of extracellular matrix related genesMMP1. The results are shown in Table 6.
TABLE 6 SEUNEU-120 bacterial lysate regulates the expression of extracellular matrix/antioxidant/autophagy/degradation of extracellular matrix-related genes
In vitro cell experiments show that the schizosaccharomyces pombe SEUNEU-120 has the I-type collagen alpha 1 chain gene related with up-regulation of HaCaT extracellular matrixCOL1A1Antioxidation-related nuclear factor E2 related factor 2 geneNRF2Cell autophagy-related microtubule-associated protein 1 light chain 3 beta geneLC3BThe expression function, the relative expression multiple of genes is 1.19-1.93; matrix metalloproteinase family genes associated with downregulation degradation of extracellular matrixMMP1The expression function, the relative expression multiple of genes is 0.18-0.82.
EXAMPLE 7 SEUNEU-120 experiments on the expression of genes involved in modulating oxidative damage of HFF extracellular matrix/antioxidant/immunomodulatory factors/inhibiting apoptosis/cell growth factors/degrading extracellular matrix/apoptosis
1. Preparation of SEUNEU-120 supernatant and thallus lysate:
the preparation is described in example 3.
2. HFF cell preparation and H 2 O 2 Induced oxidative damage
After digestion of HFF cells in DMEM culture, the cells were subjected to digestion at 0.5 ml/well (containing 2X 10 cells) 5 Cells) were inoculated into 24-well plates and incubated overnight at 37℃in a 5% carbon dioxide incubator. H was added to each well at a final concentration of 200. Mu.M 2 O 2 Stimulation was performed and the mixture was allowed to stand at 37℃for 1 hour.
3. SEUNEU-120 addition
5% (V/V) supernatant and 10% (V/V) cell lysate were added to stimulated HFF cells, respectively (control groups replaced supernatant/cell lysate with equal volumes of PBS, respectively). Each group was incubated overnight at 37℃in parallel with 3.
4. qPCR method for detecting relative expression fold of extracellular matrix/antioxidant/immunoregulatory factor/apoptosis inhibition/cell growth factor/degradation extracellular matrix/apoptosis-related gene
Removing culture medium from above cells, adding lysate, extracting total RNA of cells, detecting RNA concentration and purity, and reverse transcribing into cDNAGAPDHAs reference genes, real-time qPCR was used to detect extracellular matrix-related genesCOL13A1、SPTSSA、MKXAndSMAD3antioxidant related genesPTENAndSIRT-1immunomodulating factorsMORInhibiting apoptosis-related genesBCL-2Cell growth factor related genesFGF1、FGF2、FGF7、FGF21AndHGFdegradation of extracellular matrix-related genesMMP3And apoptosis-related genesBAXAndCaspase-9is expressed by (a). Relative expression fold f=1, using 2 for control group genes -ΔΔCT The F value of each sample was calculated by the method.
Supernatant up-regulates extracellular matrix-related genesSMAD3Antioxidant related genesSIRT-1Inhibition of apoptosisApoptotic genesBCL-2The method comprises the steps of carrying out a first treatment on the surface of the Down-regulating degradation of extracellular matrix related genesMMP3Apoptosis-related genesBAXAndCaspase-9the results are shown in Table 7.
TABLE 7 SEUNEU-120 supernatant regulates extracellular matrix/antioxidant/apoptosis-inhibiting/degradation of extracellular matrix/apoptosis-related Gene expression
Up-regulating extracellular matrix related genes by thallus lysateCOL13A1、MKXAndSPTSSAimmunomodulatory factor-related genesMORAntioxidant related genesPTENAndSIRT-1inhibiting apoptosis-related genesBCL-2Cell growth-related genesFGF1、FGF2、FGF7、FGF21AndHGF. The results are shown in Table 8.
TABLE 8 SEUNEU-120 bacterial lysate up-regulates extracellular matrix/immunomodulator/antioxidant/inhibits apoptosis/cytostatic factor-related gene expression
In vitro cell experiments show that the schizosaccharomyces pombe SEUNEU-120 has the collagen-like membrane protein 13 alpha chain gene related with up-regulation of HFF extracellular matrixCOL13A1Serine palmitoyltransferase geneSPTSSAMo Huoke protein geneMKXAnd signal transduction protein geneSMAD3Immune modulator-related beta-endorphin receptor genesMORAntioxidant related No. 10 chromosome deleted phosphatase and tensin homolog genePTENAnd Sirtuins protein family genesSIRT-1Inhibiting apoptosis-related B lymphocytoma-2 geneBCL-2And a fibroblast growth factor gene related to a cell growth factorFGF1、FGF2、FGF21Keratinocyte growth factor geneFGF7And hepatocyte growth factor geneHGFThe expression function, the relative expression times of genes are 1.06-2.81 times; has the followingMatrix metalloproteinase family genes related to modulating degradation of extracellular matrixMMP3And apoptosis-related BCL2-Associated X protein genesBAXAnd cysteine protease family genesCaspase-9The relative expression multiple of genes is 0.43-0.80.
EXAMPLE 8 SEUNEU-120 DPPH free radical scavenging ability experiment
1. Preparation of SEUNEU-120 supernatant:
the supernatant preparation method is described in example 3.
2. DPPH free radical scavenging ability assay
The reagent preparation and detection method is carried out according to the instruction of a Soxhlet DPPH free radical scavenging capacity detection kit. The 515nm absorbance of each sample was measured, averaged and the radical scavenging rate of each sample was calculated. The calculation formula is as follows: d% = [ (a blank- (a assay-a control) ]/a blank×100% and the calculation results are shown in table 9.
TABLE 9 SEUNEU-120 DPPH radical clearance (%)
The results show that the schizosaccharomyces pombe SEUNEU-120 has DPPH free radical scavenging capacity, and the DPPH free radical scavenging rate is 84.26% -87.39%.
Example 9 SEUNEU-120 Total antioxidant Capacity assay
1. Preparation of SEUNEU-120 supernatant:
the supernatant preparation method is described in example 3.
2. Total antioxidant capacity assay
The reagent preparation and detection method is carried out according to the specification of a Soxhaust total antioxidant capacity (T-AOC) detection kit, wherein the total reaction volume is 0.204ml, and the sample volume in the reaction is 0.006ml. The 593nm absorbance A of each sample was determined according to the formula: a measurement-a blank= 6.1464X-0.0009 to obtain an X value, and further to obtain the total antioxidant capacity.
The total antioxidant capacity is calculated as follows: total antioxidant capacity (μmol/mL) =x×v inverse total/V sample, calculated results are shown in table 10.
TABLE 10 SEUNEU-120 supernatant Total antioxidant Capacity (μmol/mL)
The results show that the schizosaccharomyces pombe SEUNEU-120 has an antioxidant capacity, and the total antioxidant capacity is 5.610-5.814 mu mol/mL.
In the description of the present specification, a description referring to terms "one embodiment," "some embodiments," "examples," "specific examples," or "some examples," etc., means that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the present invention. In this specification, schematic representations of the above terms do not necessarily refer to the same embodiments or examples. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
The foregoing examples illustrate only a few embodiments of the invention and are described in detail herein without thereby limiting the scope of the invention. It should be noted that it will be apparent to those skilled in the art that several variations and modifications can be made without departing from the spirit of the invention, which are all within the scope of the invention. Accordingly, the scope of protection of the present invention is to be determined by the appended claims.
Claims (7)
1. Schizosaccharomyces pombeSchizosaccharomyces pombe) SEUNEU-120 has been deposited in China center for type culture Collection with a deposit number of CCTCC NO: M20221432.
2. Use of schizosaccharomyces pombe according to claim 1 for the preparation of a pharmaceutical or cosmetic product for improving skin conditions, such as at least one of promoting cell proliferation, repairing skin barrier, moisturizing, anti-aging, such as promoting keratinocyte HaCaT proliferation.
3. The use according to claim 2, wherein the repair of the skin barrier comprises restoring cell viability and/or up-regulating expression of a barrier repair related gene comprisingFLG、IVL、OVOL1AndOCLNat least one of them.
4. The use according to claim 2, wherein the moisturizing is an up-regulating moisturizing related geneGBAIs expressed by (a).
5. The use according to claim 2, wherein said anti-aging comprises at least one of the following:
up-regulating expression of genes involved in extracellular matrix synthesis, includingCOL1A1、COL13A1、SPTSSA、SMAD3AndMKXat least one of (a) and (b);
down-regulating expression of genes associated with degradation of extracellular matrix; the genes related to the degradation of the extracellular matrix compriseMMPAt least one of the family genes;
upregulating expression of a cellular antioxidant-associated gene comprisingNRF2、PTENAndSIRT-1at least one of (a) and (b);
up-regulating cell immune regulator related geneMORIs expressed by (a);
down-regulating apoptosis-related genesBAXAnd/orCaspase-9Is expressed by (a);
upregulation of cell autophagy-related genesLC3BIs expressed by (a);
up-regulating apoptosis-inhibiting related genesBCL-2Is expressed by (a);
up-regulating expression of a cell growth factor related gene comprisingFGF1、FGF2、FGF7、FGF21AndHGFat least one of (a) and (b);
scavenging DPPH free radical;
oxidation resistance.
6. A pharmaceutical or cosmetic product for improving skin conditions, characterized by being prepared from a raw material comprising the schizosaccharomyces pombe of claim 1.
7. The pharmaceutical or cosmetic product according to claim 6, comprising the supernatant and the cell lysate of schizosaccharomyces pombe of claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310706432.3A CN116445306B (en) | 2023-06-15 | 2023-06-15 | Schizosaccharomyces pombe and its application in improving skin condition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310706432.3A CN116445306B (en) | 2023-06-15 | 2023-06-15 | Schizosaccharomyces pombe and its application in improving skin condition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116445306A CN116445306A (en) | 2023-07-18 |
| CN116445306B true CN116445306B (en) | 2023-09-01 |
Family
ID=87127666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310706432.3A Active CN116445306B (en) | 2023-06-15 | 2023-06-15 | Schizosaccharomyces pombe and its application in improving skin condition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116445306B (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103070810A (en) * | 2013-02-06 | 2013-05-01 | 成都山信药业有限公司 | Anti-skin-aging composition |
| CN105640870A (en) * | 2016-03-02 | 2016-06-08 | 名臣健康用品股份有限公司 | Skin care composition and skin care product with yeast extract |
| CN110585080A (en) * | 2019-09-16 | 2019-12-20 | 安婕妤化妆品科技股份有限公司 | Skin care product containing cracked yeast cell wall-broken extract |
| CN111840144A (en) * | 2020-09-04 | 2020-10-30 | 北京最美芳华生物科技有限公司 | Moisturizing and repairing composition, skin care product and preparation method thereof |
| DE202020107321U1 (en) * | 2020-12-16 | 2021-03-03 | Ottmar Neugebauer | Skin tightening cosmetic preparations |
| CN113337545A (en) * | 2021-06-03 | 2021-09-03 | 广东丸美生物技术股份有限公司 | Schizophyllum commune fermentation product, preparation method thereof, skin care product and schizophyllum commune culture medium |
| CN113350229A (en) * | 2021-06-16 | 2021-09-07 | 安琪酵母股份有限公司 | Glutathione-rich yeast extract, and preparation method and application thereof |
| CN114058559A (en) * | 2022-01-17 | 2022-02-18 | 山东锦鲤生物工程有限公司 | Staphylococcus epidermidis and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2843023B1 (en) * | 2002-07-30 | 2004-09-24 | Sederma Sa | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS CONTAINING KOMBUCHA. |
| CN109929883A (en) * | 2019-04-02 | 2019-06-25 | 烟台华康荣赞生物科技有限公司 | Recombination yeast, construction method and its preparing the application in tyrosol and derivative |
-
2023
- 2023-06-15 CN CN202310706432.3A patent/CN116445306B/en active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103070810A (en) * | 2013-02-06 | 2013-05-01 | 成都山信药业有限公司 | Anti-skin-aging composition |
| CN105640870A (en) * | 2016-03-02 | 2016-06-08 | 名臣健康用品股份有限公司 | Skin care composition and skin care product with yeast extract |
| CN110585080A (en) * | 2019-09-16 | 2019-12-20 | 安婕妤化妆品科技股份有限公司 | Skin care product containing cracked yeast cell wall-broken extract |
| CN111840144A (en) * | 2020-09-04 | 2020-10-30 | 北京最美芳华生物科技有限公司 | Moisturizing and repairing composition, skin care product and preparation method thereof |
| DE202020107321U1 (en) * | 2020-12-16 | 2021-03-03 | Ottmar Neugebauer | Skin tightening cosmetic preparations |
| CN113337545A (en) * | 2021-06-03 | 2021-09-03 | 广东丸美生物技术股份有限公司 | Schizophyllum commune fermentation product, preparation method thereof, skin care product and schizophyllum commune culture medium |
| CN113350229A (en) * | 2021-06-16 | 2021-09-07 | 安琪酵母股份有限公司 | Glutathione-rich yeast extract, and preparation method and application thereof |
| CN114058559A (en) * | 2022-01-17 | 2022-02-18 | 山东锦鲤生物工程有限公司 | Staphylococcus epidermidis and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| Resorcinol alleviates alpha-terpineol-induced cell death in Schizosaccharomyces pombe via increased activity of the antioxidant enzyme Sod2;Hizlan Hincal Agus等;《FEMS Yeast Res》;第22卷(第1期);foac052 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116445306A (en) | 2023-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115261273A (en) | Lactobacillus jensenii and application thereof | |
| CN115491334A (en) | Lactobacillus rhamnosus and application thereof | |
| CN116333939A (en) | Bifidobacterium breve and application thereof | |
| CN116445306B (en) | Schizosaccharomyces pombe and its application in improving skin condition | |
| CN116555070A (en) | Bifidobacterium bifidum and application thereof | |
| CN115505550A (en) | Lactobacillus paracasei and application thereof | |
| CN115584333A (en) | Lactobacillus reuteri and application thereof | |
| CN115678814A (en) | Lactobacillus salivarius and application thereof | |
| CN115369047A (en) | Kluyveromyces marxianus strain and application thereof | |
| CN115806914A (en) | Lactobacillus plantarum and application thereof | |
| CN115197856A (en) | Cordyceps militaris strain and application thereof | |
| CN114645002A (en) | Lactobacillus paracasei for skin anti-inflammation and acne treatment and application thereof | |
| CN116286415B (en) | Brevibacterium citricum strain and application thereof | |
| CN115927119B (en) | Bacillus simplex and application thereof | |
| CN115678807B (en) | Bifidobacterium longum and application thereof | |
| CN116355770B (en) | Debaryomyces hansenii and application thereof | |
| CN115820476B (en) | Lactobacillus delbrueckii and application thereof | |
| CN115287204B (en) | Kluyveromyces marxianus strain and application thereof | |
| CN116042418A (en) | Wilkham yeast strain and application thereof | |
| CN116218716A (en) | Bifidobacterium pseudocatenulatum and application thereof | |
| CN115747086A (en) | Pichia kluyveri and application thereof | |
| CN115786147A (en) | Candida rugosa and application thereof | |
| CN115927024A (en) | Saccharomyces cerevisiae and application thereof | |
| CN115820516B (en) | Bacillus subtilis and application thereof | |
| CN116478875A (en) | Bacillus cereus and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |